Mon, 22 Sep 2025

Mon, 22 Sep 2025 Pfizer boosts obesity drug prospects with $7.3 billion deal to buy Metsera

Metsera, founded in 2022, brings a pipeline of both oral and injectable treatments with different targets that could boost Pfizer's odds of entering the market.

  >>